The current global state of movement and physical activity - the health and economic costs of the inactive phenotype.


Journal

Progress in cardiovascular diseases
ISSN: 1873-1740
Titre abrégé: Prog Cardiovasc Dis
Pays: United States
ID NLM: 0376442

Informations de publication

Date de publication:
Historique:
received: 26 10 2020
accepted: 26 10 2020
pubmed: 2 11 2020
medline: 11 5 2021
entrez: 1 11 2020
Statut: ppublish

Résumé

Physical inactivity is one of the major contributing factors to the global pandemic of non-communicable diseases. Unfortunately, low levels of habitual movement and physical activity (PA) are seen in an increasing proportion of populations across low- and middle-income countries and high-income countries alike. This new normal - the inactive phenotype - is a significant contributor to multiple health and economic costs. Here we provide a brief historical overview of societal declines in PA, roughly consistent with major transitions in PA and nutrition in recent decades. This is followed by a synthesis of research evidence linking inactivity with poor health outcomes and prevention approaches needed to impact a perpetuation of poor lifestyle behaviors. A major focus of the paper is on the economic/health costs and the reduction of the inactive phenotype. In summary, we demonstrate that the consequences of insufficient PA are manifold, and if sustained, impact short and long-term health and quality of life, along with substantial economic costs.

Identifiants

pubmed: 33130190
pii: S0033-0620(20)30178-X
doi: 10.1016/j.pcad.2020.10.006
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-16

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest There is no conflict of interest to report.

Auteurs

Sisitha Jayasinghe (S)

School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.

Nuala M Byrne (NM)

School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.

Kira A E Patterson (KAE)

Faculty of Education, University of Tasmania, Launceston, TAS, Australia.

Kiran D K Ahuja (KDK)

School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia.

Andrew P Hills (AP)

School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, Australia. Electronic address: andrew.hills@utas.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH